Healthy gut microbiome improves success of cancer treatment
Summary : The largest study to date has confirmed the link between the gut microbiome and the response to cancer immunotherapy therapy…
Summary : The largest study to date has confirmed the link between the gut microbiome and the response to cancer immunotherapy therapy…
Summary : NICE has issued a positive recommendation for Arvelle Therapeutics’ cenobamate (Ontozry), for the treatment of focal-onset seizures in adults with…
Summary : British biotech company Scancell has expanded its research and development capabilities at one of the UK’s leading parks for science…
Summary : Chicago-based AbbVie has been making major decisions with company-wide impacts. The therapeutic company appears to be making changes that will…
Summary : Moderna only has a single marketed product, but it’s a blockbuster, for now at least. That product is the company’s…
Summary : For years, researchers interested in treating amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) have struggled to understand why variants…
Summary : hC Bioscience, Inc., a company focused on discovering and developing tRNA-based therapies, announced that it has raised $24 million in…
Summary : CANbridge Pharmaceuticals, Inc. (“CANbridge”, stock code 1228.HK), a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development…
Summary : Collaboration offers clinicians access to a state-of-the-art, cloud based oncology decision support platform that fully integrates the latest codified clinical…
Summary : AstraZeneca and Sanofi secured accelerated authorization for respiratory syncytial virus (RSV) antibody nirsevimab from the European Medicines Agency. Nirsevimab was…